When it comes to the latest technologies for testing, treating, and preventing the spread of covid-19, there’s no one on MIT Technology Review’s staff who’s better connected and better informed than Antonio Regalado, the magazine’s senior biomedicine editor. Since February, he’s been self-isolating with his family at their farm house in Maine, while continuing to report on the pandemic. We talked with Antonio about why it’s taking so long to scale up coronavirus testing, what new vaccine technologies look most promising, and why he started prepping for the worst way back in January.
